CA2013572A1 - Microbes non virulents et leur utilisation - Google Patents

Microbes non virulents et leur utilisation

Info

Publication number
CA2013572A1
CA2013572A1 CA002013572A CA2013572A CA2013572A1 CA 2013572 A1 CA2013572 A1 CA 2013572A1 CA 002013572 A CA002013572 A CA 002013572A CA 2013572 A CA2013572 A CA 2013572A CA 2013572 A1 CA2013572 A1 CA 2013572A1
Authority
CA
Canada
Prior art keywords
choleraesuis
gene
crp
avirulent
strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002013572A
Other languages
English (en)
Inventor
Curtiss Roy, Iii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Washington University in St Louis WUSTL
Original Assignee
Washington University
Curtiss Roy, Iii
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Washington University, Curtiss Roy, Iii filed Critical Washington University
Publication of CA2013572A1 publication Critical patent/CA2013572A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/42—Salmonella
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Amplifiers (AREA)
  • Stereophonic System (AREA)
  • Electronic Switches (AREA)
CA002013572A 1989-03-31 1990-03-30 Microbes non virulents et leur utilisation Abandoned CA2013572A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33228589A 1989-03-31 1989-03-31
US332,285 1989-03-31

Publications (1)

Publication Number Publication Date
CA2013572A1 true CA2013572A1 (fr) 1990-09-30

Family

ID=23297569

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002013572A Abandoned CA2013572A1 (fr) 1989-03-31 1990-03-30 Microbes non virulents et leur utilisation

Country Status (6)

Country Link
EP (1) EP0465561A4 (fr)
JP (1) JPH04506000A (fr)
CN (1) CN1046463A (fr)
AU (1) AU5355990A (fr)
CA (1) CA2013572A1 (fr)
WO (1) WO1990011688A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0556333B1 (fr) * 1990-11-09 2003-03-19 Washington University Salmonella microbes avirulents comprenant une modification genetique dans le gene cdt et leurs applications
FR2676068B1 (fr) * 1991-05-02 1994-11-04 Pasteur Institut Souches recombinantes immunogenes de b. anthracis - compositions immunogenes les contenant.
US5840312A (en) * 1991-05-02 1998-11-24 Institut Pasteur Recombinant Bacillus anthracis strains unable to produce the lethal factor protein or edema factor protein
US5922583A (en) * 1995-10-17 1999-07-13 Biostar Inc. Methods for production of recombinant plasmids
US6713073B1 (en) * 1998-07-24 2004-03-30 Megan Health, Inc. Method of vaccination of newly hatched poultry
WO2009025888A2 (fr) 2007-05-10 2009-02-26 The Arizona Board Of Regents For And On Behalf Of Arizona State University Expression régulée d'antigène et/ou atténuation régulée pour accroître l'immunogénicité et/ou la sécurité de vaccins
WO2009046451A1 (fr) 2007-10-05 2009-04-09 The Arizona Board Of Regents For And On Behalf Of Arizona State University Bactérie recombinante capable de susciter une réponse immunitaire protectrice contre c. perfringens
WO2010045620A1 (fr) 2008-10-17 2010-04-22 The Arizona Board Of Regents For And On Behalf Of Arizona State University Bactérie recombinante pouvant éliciter une réponse immunitaire contre le streptococcus pneumoniae
US9163219B2 (en) 2009-04-14 2015-10-20 Arizona Board Of Regents On Behalf Of Arizona State University Single expression vector for generation of a virus with a segmented genome
GB2483595B (en) 2009-05-22 2017-03-29 The Arizona Board Of Regents For And On Behalf Of Arizona State Univ Recombinant bacterium and methods of antigen and nucleic acid delivery
US9045742B2 (en) 2009-05-29 2015-06-02 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant Edwardsiella bacterium
US9062297B2 (en) 2010-01-13 2015-06-23 The Arizona Board Of Regents For And On Behalf Of Arizona State University Yersinia pestis vaccine
WO2011091291A1 (fr) 2010-01-22 2011-07-28 The Arizona Board Of Regents For And On Behalf Of Arizona State University Bactérie renfermant un acide nucléique régulé par le rfah
WO2011150421A2 (fr) 2010-05-28 2011-12-01 The Arizona Board Of Regents For And On Behalf Of Arizona State University Bactérie recombinante permettant de diminuer la croissance tumorale
US9303264B2 (en) 2012-05-18 2016-04-05 The Arizona Board Of Regents For And On Behalf Of Arizona State University Photosynthetic microorganisms expressing thermostable lipase
US9580718B2 (en) 2013-06-17 2017-02-28 Arizona Board Of Regents On Behalf Of Arizona State University Attenuated live bacteria with increased acid resistance and methods of use thereof

Also Published As

Publication number Publication date
EP0465561A1 (fr) 1992-01-15
CN1046463A (zh) 1990-10-31
EP0465561A4 (en) 1992-04-08
AU5355990A (en) 1990-11-05
WO1990011688A1 (fr) 1990-10-18
JPH04506000A (ja) 1992-10-22

Similar Documents

Publication Publication Date Title
US5468485A (en) Avirulent microbes and uses therefor
US5294441A (en) Avirulent microbes and uses therefor: salmonella typhi
AU623599B2 (en) Avirulent microbes, incapable of producing functional adenylate cyclase and cyclic amp
US4735801A (en) Novel non-reverting salmonella live vaccines
CA1335661C (fr) Vaccins vivants anti-shigella non revertants
CA2013573C (fr) Vaccins contenant des microorganismes de type phop avirulents
US4837151A (en) Live vaccines comprising two mutations and foreign antigen
EP0717777B1 (fr) Vaccins a salmonelle
US4550081A (en) Non-reverting salmonella
US5855880A (en) Avirulent microbes and uses therefor
US5643771A (en) Non-reverting live bacterial vaccines
EP0563311B1 (fr) Vaccins ameliores
CA2013572A1 (fr) Microbes non virulents et leur utilisation
CA2244807A1 (fr) Vaccin produit a partir de salmonella typhimurium
Homchampa et al. Cross protective immunity conferred by a marker-free aroA mutant of Pasteurella multocida
EP0556333B1 (fr) Salmonella microbes avirulents comprenant une modification genetique dans le gene cdt et leurs applications
WO1997020033A1 (fr) Vaccins contre les salmonelles

Legal Events

Date Code Title Description
FZDE Dead